Intervention
Dopamine
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownFractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery StenosisNCT06447740 · 2024-06-03
RECRUITINGVasopressor Agents in Pulmonary Hypertension CrisisNCT07667829 · 2026-06-01
NOT_YET_RECRUITINGAZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal ImpairmentNCT06611423 · 2024-10-15
TERMINATEDFractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension StentingNCT05732077 · 2023-01-31
UNKNOWNDiuretics and Dopamine in Heart Failure With Preserved Ejection FractionNCT01901809 · 2013-08-01
COMPLETEDStudy of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight InfantsNCT01318278 · 2011-03-01
COMPLETEDRenal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) StudyNCT01132846 · 2010-08-01
COMPLETEDCommon conditions
Renal Artery Stenosis Atherosclerotic2Secondary Hypertension Renal Arterial2Acute Heart Failure1Chronic Thromboembolic Pulmonary Hypertension (CTEPH)1Heart Failure With Reduced Ejection Fraction (HFrEF)1Heart Failure, Diastolic1Hypertension, Pulmonary1Hypotension1Pulmonary Arterial Hypertension (PAH)1Renal Impairment1
Leading sponsors
Trial status mix
COMPLETED3
NOT_YET_RECRUITING1
RECRUITING1
TERMINATED1
UNKNOWN1
Phase mix
NA4
PHASE11
PHASE21
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.